Bulls: Show Me Some Proof This Time<br />By Rev Shark<br />RealMoney.com Contributor<br />8/8/2008 8:12 AM EDT <br /><br />The quality of expectations determines the quality of our action. <br />-- Andre Godin<br /><br />The recent market bounce and the spate of bottom calls was predicated on two things: hope that banks and brokers have priced in the worst and hope that oil has topped out and will continue to trend lower. The bulls' thinking is that if those two conditions are met, then the market can deal with slowing growth, inflationary pressures and continued softness in the housing market. <br /><br />The bears tell us the optimism just isn't warranted. Banks still have many problems and are going to continue to take more write-offs as events unfold. For example, the huge charges they are now taking for the auction-rate bonds mess has not been anticipated, and there is more to come. <br /><br />The bears also argue that while declining oil prices are helpful, they are a marginal issue that will not bail out consumers who have too much debt and are lacking confidence. Job losses are accelerating, and the housing mess is still unwinding. Lower oil is a boost, but it's not a cure for more deeply rooted issues. <br /><br />Within a bear market, there is always premature optimism, and that is what keeps them going. It is human nature to be hopeful and to try to anticipate when the problems will subside, but as investors, we have to focus on protecting our capital rather then gambling on hope that maybe the optimists have it right this time. <br /><br />While we have had some slight technical improvement in the major indices over the past couple of weeks, bolstering the bull case, it is not of a sufficient degree to suggest a major trend change has taken place. In fact, it is a pretty typical bear-market bounce, where a flurry of hope stirs up a few folks who are absolutely, positively sure that this time it really is the bottom they have already called three times previously. <br /><br />While the major indices have better technical action, the trading under the surface is much more problematic. Much of the recent bounce was produced by a big rally in financials that now looks to be waning. Outside of that, we've had some leadership in medical and biotechnology stocks, and investors have shown some interest in defensive growth names such as Johnson & Johnson (JNJ) and McDonald's (MCD) . but there is little if any big and bold market leadership. And rallies we do have are very choppy, with different groups providing the strength on different days. <br /><br />For the reasons above, my confidence level in this market is quite low. I'm far more concerned about the potential downside than I am worried about missing out on a further rally. Making money in the market is more a function of moving decisively when conditions are in your favor, rather than predicting how conditions will change. I see little to indicate that we are near a major turning point. <br /><br />We had a bit of a bounce in the early going as oil is down very sharply, but Fannie Mae (FNM) earnings are putting a damper on financials once again, and we are now turning negative. <br />-------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: QLTY +66.7%, POWR +35.6%, BECN +17.9% (light volume), ENOC +11.9%, QSII +10.2%, SAPE +10.0% (also added to Top Picks List at FBR), INT +9.3%, FSYS +8.5% (also upgraded to Buy from Hold at Canaccord), FRP +8.2%, MBI +8.1%, MIDD +7.4%, PEGA +5.1%, PCR +4.7%, NVAX +4.2%, NTLS +3.5%, CHINA +3.3%, ALKS +3.0%, RBA +2.9%, RBS +2.9%, AGO +2.3%, AIRM +2.1%, APKT +2.0% (also upgraded to Buy from Hold at Cantor Fitzgerald), SD +1.9%, BRKS +1.6% (light volume), LYV +1.4%, ROSE +1.4%... M&A news: MIVA +53.8% (blinkx proposes acquisition of MIVA for $1.20 per share in cash)... Select airline stocks showing strength with crude trading lower: CAL +5.8%, LCC +4.9%, RYAAY +3.3% (also Ryanair's O'Leary eyes Stansted takeover - Daily Telegraph), AMR +3.2%, LUV +2.3%, UAUA +1.0%... Other news: ABK +8.9% (up in sympathy with MBI), S +6.0% (confirms no longer pursuing private placement of convertible preferred stock; also Google named as Sprint Nextel buyer - The Inquirer ), SNY +3.0% (gets fast-track review for Multaq heart drug), MCD +1.0% ( global comparable sales up 8.0% in July)... Analyst comments: Q +7.9% (upgraded to Overweight at Morgan Stanley), EXLS +2.9% (upgraded to Market Perform at FBR), AXA +1.0% (upgraded to Buy at Merrill).